Sandip Panicker

Sandip Panicker has extensive work experience in the field of therapeutics and scientific research. Sandip is currently the Chief Scientific Officer at Star Therapeutics, a position they have held since June 2018. Prior to this, they served as the Executive Director at Bioverativ from July 2017 to May 2018. Sandip also held various roles at True North Therapeutics, including Executive Director from April 2017 to June 2017, Director from April 2015 to April 2017, and Associate Director from August 2013 to April 2015. Sandip Panicker was an Associate Director at iPierian from November 2012 to August 2013. Before joining iPierian, they worked at Hoffman-La Roche as a Senior Scientist from November 2009 to November 2012 and as a Research Scientist from September 2007 to September 2009. Sandip began their career as a Post-doctoral Fellow at the University of California, San Francisco, where they worked from October 2004 to August 2007. Prior to that, they were a Graduate Student at the Salk Institute for Biological Studies from 1999 to 2004.

Sandip Panicker earned a B.A. degree in Molecular and Cellular Biology from the University of California, Berkeley, from 1993 to 1997. Subsequently, they pursued a Ph.D. in Neuroscience from UC San Diego, completing their studies from 1999 to 2004.